BMS-986165 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07-25 in 1mo
ESTIMATED |
READOUT
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-98
Phase 3 · Psoriasis |
BMY BRISTOL MYERS SQUIBB CO | BMS-986165 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|